4 IDEAYA/GSK presentations of IDE275 (GSK959) and 4 additional presentations across IDE397/MAT2A, IDE161/PARG, PRMT5, and KAT6/7 programs at AACR 2025 IDE275 (GSK959) has demonstrated a potential best ...
New Phase 2 data on tonlamarsen in patients with uncontrolled hypertension to be presented in late-breaking session on Saturday, March 28 Prolaio to present LINK-HF2 research highlighting the role of ...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results